Positive Ovarian Suppression medication recommendation from PBAC
So Brave received the following updated advice from PBAC this morning: PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE (PBAC) MEETING OUTCOMES ITEMS CONSIDERED OUT OF SESSION BETWEEN ORDINARY MEETINGS (JULY 2026 – SEPTEMBER 2026) https://www.pbs.gov.au/industry/listing/elements/pbac-meetings/pbac-outcomes/out-of-session/pbac-web-outcomes-OOS-08-2026.pdf In an out of session meeting, PBAC have given a positive recommendation to pharmaceutical company Ibsen for their 3.75mg Intramuscular Injection of TRIPTORELIN […]